ARCHIVES

Phase 0 Trials Signal FDA’s New Reliance On Biomarkers For Drug Development.

This article is from The Cancer Letter archive.

Vol. 32 No. 01 | January 13, 2006

Download PDF Visit The Full Archive

Related Articles

International Working Group Suggests Earlier Endpoints For HPV Vaccine Trials

August 29, 2014

FCRC Committee Limited To Review Of Basic Science

November 26, 1976

Firm To Study Imaging System As Adjunct To Mammogram.

February 25, 2000

Study Links Breast, Pancreatic Cancer Risks to Lynch Syndrome

February 24, 2012

Government Remains open Under Budget Agreement; New Deadlines Are Oct. 5 & 19

October 5, 1990

In Brief: Leaks From Cooperative Group Site Visits Vex CCIRC; Tumor Cell Cloning Workshop Set

August 11, 1978